Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation

scientific article

Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1019952369
P356DOI10.1186/1742-6405-3-21
P932PMC publication ID1609176
P698PubMed publication ID16970827
P5875ResearchGate publication ID6819846

P2093author name stringDavid Clifford
Lisa Mahnke
P2860cites workThe immune epitope database and analysis resource: from vision to blueprintQ24804461
How TCRs bind MHCs, peptides, and coreceptorsQ29619572
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapyQ33980528
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease geneQ35020128
Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequencesQ35149407
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.Q36376216
Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.Q36943282
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cellsQ39539955
Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytesQ40880429
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cellsQ46577620
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group StudyQ46878731
Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopesQ47578453
Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1.Q53850171
Evolution and transmission of stable CTL escape mutations in HIV infectionQ56880602
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemiaQ57075698
HIV-specific cytotoxic T lymphocytes in seropositive individualsQ59098667
QUASI analysis of the HIV-1 envelope sequences in the Los Alamos National Laboratory HIV sequence database: pattern and distribution of positive selection sites and their frequencies over yearsThis paper is one of a selection of papers in this SpeciaQ59191806
HIV Drug ResistanceQ59448085
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individualsQ69022796
P304page(s)21
P577publication date2006-09-14
P1433published inAIDS Research and TherapyQ15755474
P1476titleCytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation
P478volume3

Reverse relations

cites work (P2860)
Q39280285CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes
Q28480902Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection
Q28473296Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
Q41913817Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance
Q35157869The association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in southern India
Q37077668Vaccination against drug resistance in HIV infection